세계의 용련균 감염증 치료 시장 : 치료 유형별, 투여 경로별, 질환 유형별, 유통 채널별, 지역별
Global Strep Throat Treatment Market, By Treatment Type, By Route of Administration, By Disease Type, BY Distribution Channel, By Geography
상품코드:1699460
리서치사:Coherent Market Insights
발행일:2025년 03월
페이지 정보:영문
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 용련균 감염증 치료 시장은 2025년에는 20억 8,000만 달러, 2032년에는 28억 5,000만 달러에 이를 것으로 예측되며, 2025년부터 2032년에 걸쳐 CAGR 4.6%를 보일 것으로 예측됩니다.
보고 범위
보고서 세부정보
기준연도
2024년
2025년 시장 규모
20억 8,000만 달러
실적 데이터
2020-2024년
예측 기간
2025-2032년
예측 기간 : 2025-2032년 CAGR :
4.60%
2032년 가치 예측
28억 5,000만 달러
그림. 용련균 감염증 치료 세계 시장 점유율 지역별(%) 2025년
용련균 감염증은 A군 용혈성 렌사구균(GAS)에 의한 세균 감염증으로 목이나 편도선의 염증과 통증을 일으킵니다. 2022년에 설립된 연구기관인 라호야 면역학 연구소에 의한 최근의 추계에 의하면, 용연균 감염증은 세계에서 매년 6억명 이상이 이환하고 있습니다. 마치 열과 신장 질환과 같은 다른 다양한 심각한 건강 합병증을 유발할 수 있습니다. 하지만, 항생제 내성 증가가 큰 과제가 되고 있습니다.
시장 역학 :
세계의 용련균 감염증 치료 시장의 성장은 세계의 용연균 감염증의 유병률의 상승에 견인되고 있습니다. 건강 의식이 높아지고 시판되는 치료제가 쉽게 입수할 수 있다는 것도 시장의 성장을 뒷받침하고 있습니다. 또, 대체 치료법의 개발에는 긴 개발 사이클과 높은 투자 비용이 필요해, 이것이 혁신적인 연구 활동의 방해가 되고 있습니다. 또한, 제네릭 항생제 의약품 시장이 포화 상태에 있기 때문에 견고한 수익 창출 기회가 한층 더 제한됩니다.
일반 시민의 건강 의식은 높아지고 있어 증상의 완화나 류마티스열 등의 합병증 예방을 위해서 신속한 의료 어드바이스나 치료를 요구하는 사람이 늘고 있습니다. 적시 치료를 촉구하는 헬스케어 서비스나 정보 자원에의 액세스가 향상됨으로써, 더욱 강해지고 있습니다. 일반의약품(OTC)은 증상 관리를 위한 초기 수단으로, 시장의 장외 시장을 주도하고 있습니다. 이 약들이 쉽게 입수 할 수 있기 때문에 환자는 용련균 감염과 관련된 인두통의 증상을 즉시 완화 할 수 있으며 시장 전체의 성장에 기여합니다. 용연균 감염은 치료하지 않아도 증상이 완화된다는 자기 한정적인 성질을 가지고 있기 때문에 개인이 가정에서의 치료법을 선택하거나 의약품에 의한 개입을 실시하지 않기로 선택할 수 있습니다. 시장 성장의 가능성을 저해할 수 있습니다. 고액의 투자 비용은 혁신적인 연구와 의약품 개발의 억제력이 될 수 있습니다. 그러나 시장 내 기회는 약물 전달 메커니즘의 발전과 원인균인 A군 연쇄상구균에 대한 백신 개발에 있습니다. 새로운 약물 제형과 전달 기술은 치료 효과와 사용감을 향상시키고 백신은 감염증의 발생률을 크게 저하시킬 수 있습니다. 또한 인두 용연균 감염의 조기 및 정확한 발견을 용이하게하고 적절한 치료 개입을 가능하게하고 항생제의 불필요한 사용을 줄일 수있는 신속 진단 도구의 도입 준비도 갖추어져 있습니다.
예를 들어, 2021년 9월 제약 회사인 링컨 퍼머슈티컬즈는 폐렴 및 기관지염과 같은 치료에 사용되는 항생제를 생산하는 메사나 시설의 인수를 발표했습니다.
본 조사의 주요 특징
본 보고서는 세계 용련균 감염증 치료 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간(2025-2032년) 시장 규모 및 복합 연간 성장률(CAGR%)을 제공합니다.
또한 다른 부문에 걸친 잠재적인 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
엔터프라이즈 하이라이트, 제품 포트폴리오, 주요 하이라이트, 업적, 전략 등의 매개변수를 기반으로 세계 용연균 감염 치료 시장에서 주요 기업 프로파일을 제공합니다.
이 보고서의 통찰을 통해 마케팅 담당자와 기업 경영진이 향후 제품 출시, 타이핑, 시장 확대, 마케팅 전술에 대한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
세계 용련균 감염증 치료 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 지원합니다.
이해관계자들은 세계 용련균 감염증 치료 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사 결정이 용이해집니다.
목차
제1장 조사의 목적과 전제조건
조사 목적
전제조건
약어
제2장 시장 전망
보고서 설명
시장 정의와 범위
주요 요약
Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
시장 역학
영향 분석
주요 하이라이트
규제 시나리오
제품 출시/승인
PEST 분석
PORTER 분석
합병과 인수 시나리오
제4장 세계의 용련균 감염증 치료 시장-코로나바이러스(COVID-19) 팬데믹의 영향
COVID-19 역학
공급측과 수요측의 분석
경제에 미치는 영향
제5장 세계의 용련균 감염증 치료 시장, 치료 유형별, 2020년-2032년
항생제
아목시실린
페니실린
기타
진통제
기타
제6장 세계의 용련균 감염증 치료 시장, 투여 경로별, 2020년-2032년
경구
국소
주사
제7장 세계의 용련균 감염증 치료 시장, 질환 유형별, 2020년-2032년
급성 연쇄상 구균성 인두염
인두염
편도염
후두염
기타
제8장 세계의 용련균 감염증 치료 시장, 유통 채널별, 2020년-2032년
병원 약국
소매 약국
온라인 약국
제9장 세계의 용련균 감염증 치료 시장, 지역별, 2020년-2032년
북미
유럽
아시아태평양
라틴아메리카
중동
아프리카
제10장 경쟁 구도
Pfizer Inc.
Sanofi
Astrazeneca
Novartis AG
Bayer AG
GSK plc
Melinta Therapeutics
Amgen Inc.
Teva Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Company Limited
Merck & co, Inc.
Johnson & Johnson Service, Inc.
Accord Healthcare
Amneal Pharmaceuticals LLC.
MiddleBrook Pharmaceuticals, Inc.
Taiho Pharmaceutical Co., Ltd
제11장 섹션
조사 방법
출판사에 대해
SHW
영문 목차
영문목차
Global Strep Throat Treatment Market is estimated to be valued at USD 2.08 Bn in 2025 and is expected to reach USD 2.85 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.6% from 2025 to 2032.
Report Coverage
Report Details
Base Year:
2024
Market Size in 2025:
USD 2.08 Bn
Historical Data for:
2020 To 2024
Forecast Period:
2025 To 2032
Forecast Period 2025 to 2032 CAGR:
4.60%
2032 Value Projection:
USD 2.85 Bn
Figure. Global Strep Throat Treatment Market Share (%), By Region 2025
Strep throat is a bacterial infection caused by Group A Streptococcus (GAS) that results in an inflammation and soreness of the throat and tonsils. It is a very common infectious disease, especially among children aged 5-15 years. According to recent estimates provided by La Jolla Institute for Immunology, a research institute in 2022, strep throat affects over 600 million people globally each year. If left untreated, it can lead to various other severe health complications like rheumatic fever and kidney disease. The current market for strep throat treatment relies on antibiotic medications like penicillin and amoxicillin to clear the bacterial infection. However, increasing antibiotic resistance is posing a major challenge. As a result, pharmaceutical companies are focusing on developing new drugs and treatment options to effectively manage strep throat infections.
Market Dynamics:
Global strep throat treatment market growth is driven by rising prevalence of Strep throat infections worldwide. It is estimated that over 18 million cases of Strep throat occur in the U.S. alone each year. The market growth is also boosted by growing health awareness and easy availability of over-the-counter treatment drugs. However, the market potential can be restricted due to the self-limiting nature of most strep throat infections. Developing alternative treatment approaches also involves long development cycles and high investment costs which hinders innovative research activities. Moreover, market saturation of generic antibiotic drugs further limits robust revenue generation opportunities. Nevertheless, the market is presented with opportunities to address the unmet needs through novel drug delivery technologies and vaccines against Strep throat.
Health awareness among the general populace has increased, with more people seeking prompt medical advice and treatment for symptomatic relief and to prevent complications such as rheumatic fever. This awareness is bolstered by greater access to healthcare services and information resources that encourage timely treatment of Strep throat. Over-the-counter (OTC) medications serve as an initial resort for symptom management, driving the OTC segment of the market. The easy availability of these drugs contributes to the overall market growth, providing patients with immediate access to relief from sore throat symptoms associated with Strep infections. However, the inherent self-limiting nature of most Strep throat infections, where symptoms resolve without treatment, can impede market growth potential as individuals may opt for home remedies or choose not to pursue pharmaceutical interventions. Developing new and improved treatments for Strep throat can be a costly and time-intensive endeavor, often marked by long development cycles. High investment costs can act as a deterrent for innovative research and drug development. Yet, opportunities within the market lie in the advancement of drug delivery mechanisms and the development of vaccines against the causative bacteria, Group A Streptococcus. Novel drug formulations and delivery technologies can enhance treatment efficacy and user experience, while vaccines could significantly reduce the incidence of infections. The market is also ready for the introduction of rapid diagnostic tools, which could facilitate early and accurate detection of Strep throat infections, allowing for appropriate treatment interventions and reducing unnecessary use of antibiotics.
For instance, in September 2021, Lincoln Pharmaceuticals Ltd, a pharmaceutical company, announced the acquisition of facility in Mehsana that makes antibiotics used in the treatment of pneumonia and bronchitis, among other ailments.
Key features of the study:
This report provides in-depth analysis of the global strep throat treatment market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global strep throat treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer Inc., Sanofi, Astrazeneca, Novartis AG, Bayer AG, GSK plc, Melinta Therapeutics, Amgen Inc., Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Merck & co, Inc., Johnson & Johnson Service, Inc., Accord Healthcare, Amneal Pharmaceuticals LLC., MiddleBrook Pharmaceuticals, Inc., and Taiho Pharmaceutical Co., Ltd
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global strep throat treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global strep throat treatment market
Global Strep Throat Treatment Market- Segmentation
By Treatment Type
Antibiotics
Amoxicillin
Penicillin
Others
Pain Relievers
Others
By Route of Administration
Oral
Topical
Injectable
By Disease Type
Acute Strep Throat
Pharyngitis
Tonsillitis
Laryngitis
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
Company Profiles
Pfizer Inc.
Sanofi
Astrazeneca
Novartis AG
Bayer AG
GSK plc
Melinta Therapeutics
Amgen Inc.
Teva Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Company Limited
Merck & co, Inc.
Johnson & Johnson Service, Inc.
Accord Healthcare
Amneal Pharmaceuticals LLC.
MiddleBrook Pharmaceuticals, Inc.
Taiho Pharmaceutical Co., Ltd
Table of Contents
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Global Strep Throat Treatment Market, By Treatment Type
Global Strep Throat Treatment Market, By Route of Administration
Global Strep Throat Treatment Market, By Disease Type
Global Strep Throat Treatment Market, By Distribution Channel
Global Strep Throat Treatment Market, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Driver
Rising prevalence of streptococcal infections
Increasing awareness about streptococcal infections
Growing investments in research and development (R&D)
Government support and initiatives
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
4. Global Strep Throat Treatment Market - Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Global Strep Throat Treatment Market, By Treatment Type, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Antibiotics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Amoxicillin
Penicillin
Others
Pain Relievers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
6. Global Strep Throat Treatment Market, By Route of Administration, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021-2032
Segment Trends
Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Topical
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Injectable
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
7. Global Strep Throat Treatment Market, By Disease Type, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021-2032
Segment Trends
Acute Strep Throat
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Pharyngitis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Tonsillitis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Laryngitis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
8. Global Strep Throat Treatment Market, By Distribution Channel, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021-2032
Segment Trends
Hospital Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Retail Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Online Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
9. Global Strep Throat Treatment Market, By Region, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, By Region, 2025 and 2032 (%)
Y-o-Y Growth Analysis, For Region, 2020-2032
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032 ,(US$ Bn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
